These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34382749)

  • 1. Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective.
    Ahmed FZ; Taylor JK; John AV; Khan MA; Zaidi AM; Mamas MA; Motwani M; Cunnington C
    ESC Heart Fail; 2021 Oct; 8(5):3906-3916. PubMed ID: 34382749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure.
    Buckley LF; Seoane-Vazquez E; Cheng JW; Aldemerdash A; Cooper IM; Matta L; Medina DS; Mehra MR; Navarro-Velez K; Shea EL; Weintraub JR; Stevenson LW; Desai AS
    Am J Cardiol; 2016 Nov; 118(9):1350-1355. PubMed ID: 27772698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature.
    Wierda E; Dickhoff C; Handoko ML; Oosterom L; Kok WE; de Rover Y; de Mol BAJM; van Heerebeek L; Schroeder-Tanka JM
    ESC Heart Fail; 2020 Jun; 7(3):892-902. PubMed ID: 32159279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study.
    Bensimhon D; Weintraub WS; Peacock WF; Alexy T; McLean D; Haas D; Deering KL; Millar SJ; Goodwin MM; Mohr JF
    Future Cardiol; 2023 Jun; 19(8):385-396. PubMed ID: 37609913
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
    Gilotra NA; Princewill O; Marino B; Okwuosa IS; Chasler J; Almansa J; Cummings A; Rhodes P; Chambers J; Cuomo K; Russell SD
    JACC Heart Fail; 2018 Jan; 6(1):65-70. PubMed ID: 29226816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory Intravenous Diuretic Clinic Associated with Short-Term Risk Reduction in Mortality and Rehospitalizations in Patients Discharged with Heart Failure.
    St Amand A; Taveira TH; Henthorne KE; Wu WC
    R I Med J (2013); 2020 Nov; 103(9):16-21. PubMed ID: 33126781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure.
    Fudim M; Spates T; Sun JL; Kittipibul V; Testani JM; Starling RC; Tang WHW; Hernandez AF; Felker GM; O'Connor CM; Mentz RJ
    Am Heart J; 2021 Sep; 239():110-119. PubMed ID: 34052212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).
    Hamo CE; Abdelmoneim SS; Han SY; Chandy E; Muntean C; Khan SA; Sunkesula P; Meykler M; Ramachandran V; Rosenberg E; Klem I; Sacchi TJ; Heitner JF
    PLoS One; 2021; 16(6):e0253014. PubMed ID: 34170908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic.
    Herrera-Leaño N; Barahona-Correa JE; Muñoz-Velandia O; Fernández-Ávila DG; Mariño-Correa A; Alberto García Á
    Ther Adv Cardiovasc Dis; 2023; 17():17539447231184984. PubMed ID: 37417658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IV Diuresis in Alternative Treatment Settings for the Management of Heart Failure: Implications for Mortality, Hospitalizations and Cost.
    Jiang GY; Lee C; Kearing SA; Wadhera RK; Gavin MC; Wasfy JH; Zeitler EP
    J Card Fail; 2024 Jan; 30(1):4-11. PubMed ID: 37714260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
    Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic.
    Vaishnav J; Hubbard A; Chasler JE; Lepley D; Cuomo K; Riley S; Menzel K; Fajardo J; Sharma K; Judge DP; Russell SD; Gilotra NA
    Am Heart J; 2021 Mar; 233():122-131. PubMed ID: 33352187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic lounge and the impact on hospital admissions for treatment of decompensated heart failure.
    Ioannou A; Browne T; Jordan S; Metaxa S; Mandal AKJ; Missouris CG
    QJM; 2020 Sep; 113(9):651-656. PubMed ID: 32251503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.